000 | 00984nam a22002417a 4500 | ||
---|---|---|---|
003 | inmoiis | ||
008 | 201026b ||||| |||| 00| 0 eng d | ||
020 | _axx | ||
040 |
_bEng. _cIISER Mohali |
||
041 | _aEng. | ||
100 | _aSrivastava, Anup Kumar [PH13046] | ||
245 |
_aHybrid nanostructures mediated biosensing and epigenetically controlled neurotherapeutic applications in neurodegenerative diseases/ _cAnup Kumar Srivastava, Surajit Karmakar |
||
260 |
_aIISER Mohali: _bDepartment of Biological Science, _cDecember 2019. |
||
300 |
_a146p.: _bill; _c29cm. |
||
502 |
_APH13046 _aDr. Surajit Karmakar _b2013 _cDecember 2019 _eDepartment of Biological Science _fPH |
||
650 | _aManagement of AD | ||
650 | _aAβ clearance pathway | ||
650 | _aMolecular pathobiology of PD | ||
650 | _aTargeting Aβ aggregation kinetics | ||
700 | _aSupervisor name- Dr. Karmakar, Surajit | ||
856 | _uhttp://210.212.36.82:8080/jspui/handle/123456789/1581 | ||
942 |
_2ddc _cTHESIS |
||
999 |
_c13881 _d13881 |